dc.contributor
Institut Català de la Salut
dc.contributor
[Serrano C] Sarcoma Translational Research Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Álvarez R] Hospital General Universitario Gregorio Marañón, Madrid, Spain. [Carrasco JA] Hospital Álvaro Cunqueiro–Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain. [Marquina G] Hospital Universitario Clínico San Carlos, Madrid, Spain. [Martínez-García J] Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. [Martínez-Marín V] Hospital Universitario la Paz, Madrid, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Carrasco, Juan Antonio
dc.contributor.author
Marquina, Gloria
dc.contributor.author
Martinez-Garcia, Jeronimo
dc.contributor.author
MARTÍNEZ MARÍN, VIRGINIA
dc.contributor.author
ALVAREZ, ROSA
dc.contributor.author
Serrano, Cesar
dc.date.issued
2023-09-05T12:07:25Z
dc.date.issued
2023-09-05T12:07:25Z
dc.identifier
Serrano C, Álvarez R, Carrasco JA, Marquina G, Martínez-García J, Martínez-Marín V, et al. SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clin Transl Oncol. 2023 Sep;25:2707–17.
dc.identifier
https://hdl.handle.net/11351/10233
dc.identifier
10.1007/s12094-023-03177-7
dc.identifier
000980351000001
dc.description.abstract
Avapritinib; Imatinib; Ripretinib
dc.description.abstract
Avapritinib; Imatinib; Ripretinib
dc.description.abstract
Avapritinib; Imatinib; Ripretinib
dc.description.abstract
Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of mesenchymal origin, and a paradigmatic model for a successful rational development of targeted therapies in cancer. The introduction of tyrosine kinase inhibitors with activity against KIT/PDGFRA in both localized and advanced stages has remarkably improved the survival in a disease formerly deemed resistant to all systemic therapies. These guidelines are elaborated by the conjoint effort of the Spanish Society of Medical Oncology (SEOM) and the Spanish Sarcoma Research Group (GEIS) and provide a multidisciplinary and updated consensus for the diagnosis and treatment of GIST patients. We strongly encourage that the managing of these patients should be performed within multidisciplinary teams in reference centers.
dc.format
application/pdf
dc.relation
Clinical and Translational Oncology;25
dc.relation
https://doi.org/10.1007/s12094-023-03177-7
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Decisió de grup
dc.subject
Tracte gastrointestinal - Càncer - Tractament
dc.subject
Tracte gastrointestinal - Càncer - Diagnòstic
dc.subject
DISEASES::Digestive System Diseases::Digestive System Neoplasms::Gastrointestinal Neoplasms::Digestive System Diseases::Gastrointestinal Stromal Tumors
dc.subject
PUBLIC HEALTH::Health Care (Public Health)::Delivery of Health Care::Disease Management
dc.subject
PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Psychology, Social::Group Processes::Consensus
dc.subject
ENFERMEDADES::enfermedades del sistema digestivo::neoplasias del sistema digestivo::neoplasias gastrointestinales::enfermedades del sistema digestivo::tumores del estroma gastrointestinal
dc.subject
SALUD PÚBLICA::atención a la salud (salud pública)::prestación sanitaria::tratamiento de las enfermedades
dc.subject
PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::psicología social::procesos de grupo::consenso
dc.title
SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
